Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Gianpaolo Perletti, Alberto Trinchieri, Konstantinos Stamatiou & Vittorio Magri. (2022) Safety considerations with new antibacterial approaches for chronic bacterial prostatitis. Expert Opinion on Drug Safety 21:2, pages 171-182.
Read now
Read now
Dario Cattaneo, Jan-Willem Alffenaar & Michael Neely. (2016) Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones. Expert Opinion on Drug Metabolism & Toxicology 12:5, pages 533-544.
Read now
Read now
Articles from other publishers (18)
Abhijit M. Bal. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
201
212
.
Jie Fang, Xiao-Shan Zhang, Chun-Hong Zhang, Zi-Ye Zhou, Lu Han, Ye-Xuan Wang, Xiao-Shuang He, Xiao-Lan Bian, Guan-Yang Lin, Zheng Jiao, Ying Dai, Xu-Ben Yu & Jing-Ye Pan. (2021) Model Based Identification of Linezolid Exposure–toxicity Thresholds in Hospitalized Patients. Frontiers in Pharmacology 12.
Crossref
Crossref
Lola V. Stamm. (2021) Hope for new antibiotics for syphilis treatment. eBioMedicine 66, pages 103320.
Crossref
Crossref
Junzhen Wu, Hailan Wu, Yu Wang, Yuancheng Chen, Beining Guo, Guoying Cao, Xiaojie Wu, Jicheng Yu, Jufang Wu, Demei Zhu, Yan Guo, Hong Yuan, Fupin Hu & Jing Zhang. (2019) Tolerability and Pharmacokinetics of Contezolid at Therapeutic and Supratherapeutic Doses in Healthy Chinese Subjects, and Assessment of Contezolid Dosing Regimens Based on Pharmacokinetic/Pharmacodynamic Analysis. Clinical Therapeutics 41:6, pages 1164-1174.e4.
Crossref
Crossref
Lélia Abad, Virginie Tafani, Jason Tasse, Jérôme Josse, Christian Chidiac, Sébastien Lustig, Tristan Ferry, Alan Diot, Frédéric Laurent & Florent Valour. (2019)
Evaluation of the ability of linezolid and tedizolid to eradicate intraosteoblastic and biofilm-embedded
Staphylococcus aureus
in the bone and joint infection setting
. Journal of Antimicrobial Chemotherapy 74:3, pages 625-632.
Crossref
Crossref
Tamara V. Milosevic, Valéry L. Payen, Pierre Sonveaux, Giulio G. Muccioli, Paul M. Tulkens & Françoise Van Bambeke. (2018) Mitochondrial Alterations (Inhibition of Mitochondrial Protein Expression, Oxidative Metabolism, and Ultrastructure) Induced by Linezolid and Tedizolid at Clinically Relevant Concentrations in Cultured Human HL-60 Promyelocytes and THP-1 Monocytes. Antimicrobial Agents and Chemotherapy 62:3.
Crossref
Crossref
Alexander P. Glaser & Anthony J. Schaeffer. (2015) Urinary Tract Infection and Bacteriuria in Pregnancy. Urologic Clinics of North America 42:4, pages 547-560.
Crossref
Crossref
Joseph Buensalido, Carmen DeMarco & Stephen Lerner. 2015. Practical Handbook of Microbiology, Third Edition. Practical Handbook of Microbiology, Third Edition
153
182
.
Michael J. Schlosser, Hiromi Hosako, Ann Radovsky, Mark T. Butt, Dragomir Draganov, Jenifer Vija & Frederick Oleson. (2015) Lack of Neuropathological Changes in Rats Administered Tedizolid Phosphate for Nine Months. Antimicrobial Agents and Chemotherapy 59:1, pages 475-481.
Crossref
Crossref
Shawn Flanagan, Edward E. McKee, Debaditya Das, Paul M. Tulkens, Hiromi Hosako, Jill Fiedler-Kelly, Julie Passarell, Ann Radovsky & Philippe Prokocimer. (2015) Nonclinical and Pharmacokinetic Assessments To Evaluate the Potential of Tedizolid and Linezolid To Affect Mitochondrial Function. Antimicrobial Agents and Chemotherapy 59:1, pages 178-185.
Crossref
Crossref
S. Harbarth, E. von Dach, L. Pagani, M. Macedo-Vinas, B. Huttner, F. Olearo, S. Emonet & I. Uckay. (2014) Randomized non-inferiority trial to compare trimethoprim/sulfamethoxazole plus rifampicin versus linezolid for the treatment of MRSA infection. Journal of Antimicrobial Chemotherapy 70:1, pages 264-272.
Crossref
Crossref
Sung-Ji Jung, I-Na-Rae Yun, Hee Soo Park, Hyun-Hee Lee, Ji-Woong Jeong, Yong-Zu Kim, Young-Lak Cho & Jin-Hwan Kwak. (2012) Antibacterial activity of LCB01-0062, a novel oxazolidinone. International Journal of Antimicrobial Agents 40:6, pages 539-543.
Crossref
Crossref
A. Simon, E. Müllenborn, M. Prelog, W. Schenk, J. Holzapfel, F. Ebinger, A. Klabunde-Cherwon, J. Faber, A. H. Groll, K. Masjosthusmann, C. Dohna-Schwake, K. Beutel, E. Dirkwinkel, T. Lehrnbecher, R. A. Ammann & A. Müller. (2011) Use of linezolid in neonatal and pediatric inpatient facilities—results of a retrospective multicenter survey. European Journal of Clinical Microbiology & Infectious Diseases 31:7, pages 1435-1442.
Crossref
Crossref
S. Garazzino, A. Krzysztofiak, S. Esposito, E. Castagnola, A. Plebani, L. Galli, M. Cellini, R. Lipreri, C. Scolfaro, C. Bertaina, C. Calitri, E. Bozzola, L. Lancella, A. Quondamcarlo, S. Bosis, L. Pugni, G. Losurdo, A. Soresina, M. De Gaudio, I. Mariotti, L. Mancini, C. Gabiano & P.-A. Tovo. (2011) Use of linezolid in infants and children: a retrospective multicentre study of the Italian Society for Paediatric Infectious Diseases. Journal of Antimicrobial Chemotherapy 66:10, pages 2393-2397.
Crossref
Crossref
Natascia Corti, Anne Taegtmeyer & Alexander Imhof. 2011. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions
509
540
.
Gwendolyn A. Marriner, Amit Nayyar, Eugene Uh, Sharon Y. Wong, Tathagata Mukherjee, Laura E. Via, Matthew Carroll, Rachel L. Edwards, Todd D. Gruber, Inhee Choi, Jinwoo Lee, Kriti Arora, Kathleen D. England, Helena I. M. Boshoff & Clifton E. BarryIIIIII. 2011. Third World Diseases. Third World Diseases
47
124
.
Elena Chiappini, Camilla Conti, Luisa Galli & Maurizio de Martino. (2010) Clinical efficacy and tolerability of linezolid in pediatric patients: A systematic review. Clinical Therapeutics 32:1, pages 66-88.
Crossref
Crossref
Jacyntha A. Sterling. (2009) Recent Publications on Medications and Pharmacy. Hospital Pharmacy 44:9, pages 822-828.
Crossref
Crossref